Frederique Mariette - Publications

De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

Journal: Tumori

Published: September 11, 2023

OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma.

Journal: Biomedicines

Published: April 27, 2022

Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis.

Journal: Tumori

Published: May 10, 2019

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Journal: Gynecologic oncology

Published: March 09, 2015

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: October 23, 2014

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

Journal: Breast cancer research : BCR

Published: January 01, 2014

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

Journal: PLoS genetics

Published: October 23, 2013

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

Journal: British journal of cancer

Published: September 04, 2013

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.

Journal: Journal of medical genetics

Published: February 28, 2012

Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.

Journal: PloS one

Published: November 08, 2011